E. Vagia

Most-cited papers

1. B-cell infiltration is associated with survival outcomes following programmed cell death protein 1 inhibition in head and neck squamous cell carcinoma.

   N. Gavrielatou, E. Fortis, A. Spathis, M. Anastasiou +16 more

   2023Annals of Oncology48 citations Open access

   Semantic Scholar

   Save

2. Prognostic impact of indoleamine 2,3-dioxygenase 1 (IDO1) mRNA expression on circulating tumour cells of patients with head and neck squamous cell carcinoma

   P. Economopoulou, Athina Kladi-Skandali, A. Strati, George Koytsodontis +13 more

   2020ESMO Open25 citations Open access

   Semantic Scholar

   Save

3. Patterns of Response to Immune Checkpoint Inhibitors in Association with Genomic and Clinical Features in Patients with Head and Neck Squamous Cell Carcinoma (HNSCC)

   P. Economopoulou, M. Anastasiou, G. Papaxoinis, N. Spathas +12 more

   2021Cancers22 citations Open access

   Semantic Scholar

   Save

4. Androgen-Receptor Positive Lacrimal Sac Adenocarcinoma Demonstrating Long-Lasting Response to LHRH Analog Plus Abiraterone Treatment

   E. Vagia, P. Economopoulou, N. Oikonomopoulos, I. Athanasiadis +2 more

   2015Frontiers in Oncology15 citations Open access

   Semantic Scholar

   Save

5. Predisposing Germline Mutations in Young Patients With Squamous Cell Cancer of the Oral Cavity.

   F. Fostira, G. Koutsodontis, E. Vagia, P. Economopoulou +5 more

   2018JCO Precision Oncology14 citations

   Semantic Scholar

   Save

6. Surrogates of immunologic cell death (ICD) and chemoradiotherapy outcomes in head and neck squamous cell carcinoma (HNSCC).

   P. Economopoulou, G. Koutsodontis, A. Strati, Efthymios Kirodimos +13 more

   2018Oral Oncology13 citations

   Semantic Scholar

   Save

7. PDL1-expressing circulating tumor cells (CTCs) in head and neck squamous cell carcinoma (HNSCC).

   G. Koutsodontis, A. Strati, M. Avgeris, E. Maratou +14 more

   20154 citations

   Semantic Scholar

   Save

8. Clinical implications of hyperprogression with immune checkpoint inhibitors in patients with head and neck squamous cell carcinoma (HNSCC).

   P. Economopoulou, N. Spathas, G. Papaxoinis, M. Anastasiou +8 more

   2019Journal of Clinical Oncology2 citations

   Semantic Scholar

   Save

9. Predictive biomarkers for response to nivolumab in head and neck squamous cell carcinoma (HNSCC) (NCT#03652142).

   A. Psyrri, N. Gavrielatou, A. Spathis, M. Anastasiou +11 more

   2019Journal of Clinical Oncology2 citations

   Semantic Scholar

   Save

10. 215P Differential spatial gene expression and clinicopathologic characteristics are associated with exceptional response to immune checkpoint inhibition in recurrent/metastatic head and neck cancer

    N. Gavrielatou, A. Spathis, M. Anastasiou, P. Economopoulou +9 more

    2024Immuno-Oncology and Technology0 citations Open access

    Semantic Scholar

    Save

11. Abstract 1256: B-cell infiltration is associated with survival outcomes in nivolumab-treated head and neck squamous cell carcinoma (HNSCC): NCT 03652142

    N. Gavrielatou, E. Fortis, A. Spathis, M. Anastasiou +12 more

    2022Cancer Research0 citations

    Semantic Scholar

    Save

12. P-78 Predictive biomarkers for response to nivolumab in head and neck squamous cell carcinoma (HNSCC) (NCT#03652142)

    N. Gavrielatou, M. Anastasiou, E. Fortis, M. Gkotzamanidou +8 more

    2021Oral Oncology0 citations

    Semantic Scholar

    Save

13. Abstract 2152: Oncolytic virus (RT3D) administration in combination with cetuximab in head and neck squamous cell cancer (HNSCC) models harboring active EGFR/RAS/PI3K signaling

    A. Psyrri, P. Economopoulou, I. Kotsantis, V. Ramfidis +4 more

    20150 citations

    Semantic Scholar

    Save

14. Dynamic changes in epithelial to mesenchymal composition and prognostic relevance of circulating cancer cells (CTCs) in head and neck squamous cell carcinoma (HNSCC).

    E. Vagia, G. Koutsodontis, A. Strati, A. Giagini +12 more

    20140 citations

    Semantic Scholar

    Save